mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |